Vol.71 No.3 May 2023
Surveillance of the actual status of measures taken to prevent antimicrobial resistance by medical facilities across Japan in 2010 and 2016
1)Department of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, 5 misasagi-nakauchi, Yamashina-ku, Kyoto, Japan
2)AMR Clinical Reference Center, Disease Control and Prevention Center, National Center for Global Health and Medicine
Abstract
Antimicrobial resistance (AMR) is a global health threat. In Japan, measures to curb AMR have included the establishment of medical fees that emphasize nosocomial infection control and infection control teams and antimicrobial stewardship teams. However, the actual status in various types of facilities across Japan at the time of establishment of these measures remains unclear. Therefore, we collected responses to questions registered in the Japan Antimicrobial Consumption Surveillance (JACS) and surveyed the actual status of measures taken by medical facilities to prevent AMR at the time of implementation of the infection prevention and control premium (IPCP) in 2010 and at the time that a national action plan was instituted in 2016. The subjects of this study were 70 and 93 facilities for survey of the status in 2010 and 2016, respectively. The number of facilities claiming IPCP increased from 2010 (38.6%, 27/70) to 2016 (95.7%, 89/93), and efforts to prevent infection became more proactive. The facilities claiming IPCP had a higher rate of enrollment of specialized/certified pharmacists and conducted more antimicrobial stewardship (AS) activities, suggesting that disparities existed among facilities. It is necessary to continuously evaluate AS activities in the future, after establishing an environment in which specialized/certified pharmacists are assigned to each medical institution.
Key word
antimicrobial stewardship, antimicrobial resistance, surveillance
Received
January 18, 2023
Accepted
March 8, 2023
Jpn. J. Chemother. 71 (3): 326-331, 2023
